Work

POSTER: IBCL-770 Matching-Adjusted Indirect Comparison of Epcoritamab With Rituximab + Lenalidomide Versus Tafasitamab With Rituximab + Lenalidomide in Second-Line or Later Follicular Lymphoma

Year: 2025

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(25)01128-0

Authors: Julie M. Vose, Paolo F. Caimi, Yasmin H. Karimi, Ke Yang, Zhijie Ding, Tongsheng Wang, Savreet Bains Chawla, Fernando Rivas Navarro, Felipe Marques Goncalves, Ali Rana, Elena Favaro, Anthony Wang, Alex Mutebi, Kim M. Linton

Institutions: University of Nebraska Medical Center, Cleveland Clinic, University of Michigan, Genmab (United States), AbbVie (United States), Genmab (Denmark), University of Manchester, The Christie NHS Foundation Trust, Cancer Research UK Manchester Centre

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4413776584

FWCI:

Cites:

Cited by:

Related to: 10